Healthcare Giants: Diverging Paths and Future Outlook
Healthcare Giants Diverge: Johnson & Johnson’s Oncology Focus vs. Abbott’s Diagnostic Expansion Johnson & Johnson (NYSE:JNJ) and Abbott Laboratories (NYSE:ABT) are currently pursuing distinct strategic paths, with JNJ tightening its focus on innovative medicine while Abbott aggressively expands its diagnostic footprint. JNJ’s Q1 report highlighted an 11.2% revenue increase in its Innovative Medicine segment, driven … Read more